Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) EPS (Basic): 2011-2025

Historic EPS (Basic) for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to -$2.26.

  • Aytu Biopharma's EPS (Basic) rose 219.95% to $0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 117.98%. This contributed to the annual value of -$2.26 for FY2025, which is 20.98% up from last year.
  • Aytu Biopharma's EPS (Basic) amounted to -$2.26 in FY2025, which was up 20.98% from -$2.86 recorded in FY2024.
  • Aytu Biopharma's 5-year EPS (Basic) high stood at -$2.26 for FY2025, and its period low was -$74.01 during FY2022.
  • In the last 3 years, Aytu Biopharma's EPS (Basic) had a median value of -$2.86 in 2024 and averaged -$3.41.
  • Per our database at Business Quant, Aytu Biopharma's EPS (Basic) plummeted by 2,026.72% in 2022 and then spiked by 93.10% in 2023.
  • Over the past 5 years, Aytu Biopharma's EPS (Basic) (Yearly) stood at -$3.48 in 2021, then slumped by 2,026.72% to -$74.01 in 2022, then surged by 93.10% to -$5.11 in 2023, then spiked by 44.03% to -$2.86 in 2024, then climbed by 20.98% to -$2.26 in 2025.